NCT06605222View on ClinicalTrials.gov

A Trial of SHR-7787 Injection in Patients With Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

October 4, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

November 30, 2026

Conditions
Advanced Solid Tumors
Interventions
DRUG

SHR-7787 injection

Firstly Dose Escalation and Dose Expansion of SHR-7787 injection monotherapy should be conducted.

Trial Locations (1)

200433

RECRUITING

Shanghai Pulmonary Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Hengrui Pharmaceutical Co., Ltd.

INDUSTRY